Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Change in Receivables (2020 - 2025)

Bio Essence (BIOE) has 6 years of Change in Receivables data on record, last reported at $187639.0 in Q3 2025.

  • For Q3 2025, Change in Receivables rose 225.86% year-over-year to $187639.0; the TTM value through Sep 2025 reached $131669.0, up 142.63%, while the annual FY2024 figure was $197294.0, 5468.54% up from the prior year.
  • Change in Receivables reached $187639.0 in Q3 2025 per BIOE's latest filing, up from -$190861.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $197295.0 in Q1 2024 and bottomed at -$190861.0 in Q2 2025.
  • Average Change in Receivables over 5 years is $9077.2, with a median of $2455.0 recorded in 2022.
  • The widest YoY moves for Change in Receivables: up 3766.26% in 2024, down 631456.67% in 2024.
  • A 5-year view of Change in Receivables shows it stood at -$4733.0 in 2021, then tumbled by 559.86% to -$31231.0 in 2022, then skyrocketed by 64.13% to -$11202.0 in 2023, then skyrocketed by 1276.79% to $131824.0 in 2024, then soared by 42.34% to $187639.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $187639.0 in Q3 2025, -$190861.0 in Q2 2025, and $3067.0 in Q1 2025.